<DOC>
	<DOCNO>NCT01489332</DOCNO>
	<brief_summary>The use capecitabine base preoperative chemoradiation adjuvant chemotherapy standard treatment locally advanced rectal cancer . It reduce local recurrence rate le 10 % , limited effect overall survival due constantly high ( 30 % ) rate distant metastasis . Complete eradication primary tumour observe histopathological specimen ( pathological complete response , pCR ) correlate favourable overall prognosis obtain pCR might beneficial . The aim study investigate whether addition capecitabine base chemotherapy preoperative chemoradiation also operation improve pathological complete remission rate locally advance rectal cancer acceptable toxicity . Secondary objective evaluate pathological downstaging rate , histopathological R0 resection rate , sphincter preservation rate , perioperative surgical complication rate , local control , DFS , OS , late toxicity quality life .</brief_summary>
	<brief_title>Induction Chemotherapy , Radiochemotherapy , Consolidation Chemotherapy Preoperative Treatment Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Male female patient histologically proven adenocarcinoma rectum ( tumour locate peritoneum ) , T3/4 node positive disease ( clinical stage accord TNM classification system ) No evidence metastatic disease . The disease must consider either resectable time entry think become resectable preoperative chemoradiation . Age 18 year WHO Performance Status 02 No prior radiotherapy , chemotherapy target therapy rectal cancer Adequate hematological , hepatic renal function Ability swallow tablet Signed informed consent Patients must willing able comply protocol duration study Malignancy rectum adenocarcinoma Any unrested synchronous colon cancer Other coexist malignancy malignancy within past 5 year , exception adequately treat situ carcinoma cervix basal cell carcinoma skin Significant heart disease ( uncontrolled hypertension despite medication ( &gt; 150/100 mmHg ) , NYHA class III IV heart disease , unstable angina myocardial infarction within past 1 year prior study entry , history significant ventricular arrhythmia require treatment ) Pregnant lactate patient Females positive pregnancy test unless childbearing potential otherwise exclude ( amenorrheic least 2 year , hysterectomy oophorectomy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>rectal cancer</keyword>
	<keyword>capecitabine</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>locally advanced rectal cancer</keyword>
</DOC>